Cargando…
Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation
HCC is a highly lethal tumor, and orthotopic liver transplantation, as one of the radical treatment methods for HCC, has opened-up a new therapeutic approach for the treatment of primary liver cancer. However, tumor recurrence after liver transplantation is the main reason that affects the long-term...
Autores principales: | Jin, Xin, Ma, Xiaoting, Zhao, Dong, Yang, Lin, Ma, Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794975/ https://www.ncbi.nlm.nih.gov/pubmed/36542991 http://dx.doi.org/10.1016/j.tranon.2022.101603 |
Ejemplares similares
-
Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022) -
Late Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Chok, Kenneth S. H., et al.
Publicado: (2011) -
Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Kim, Bo Hyun, et al.
Publicado: (2018) -
Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation
por: Pelizzaro, Filippo, et al.
Publicado: (2021) -
Imaging of hepatocellular carcinoma recurrence after liver transplantation
por: Mamone, Giuseppe, et al.
Publicado: (2023)